These T cells were able to recognize various PRAME-expressing cell lines derived from melanoma, acute myeloid leukemia, colon carcinoma, cervix carcinoma, and lung and breast cancer, whereas acute lymphoblastic leukemia cells were only recognized after CD40L-activation of the T cell clones. Here, PRAME is linked to melanoma.